S Sherry. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Heparin/administration & dosageHeparin/adverse effectsHeparin/therapeutic useHumansInjections, SubcutaneousPostoperative Complications/prevention & controlPulmonary Embolism/prevention & controlThromboembolism/prevention & controlThrombophlebitis/prevention & controlTime Factors
Substances: See more » Heparin
Year: 1975 PMID: 1138184 DOI: 10.1056/NEJM197508072930612
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245